Clinical Trials on Influenza in Birds in United States

Total 3493 results

Sanofi Pasteur, a Sanofi Company

Completed

Phase IV Trial to Collect Safety Data and Sera for Immunogenicity Testing in Healthy Children Given Fluzone® Vaccine

Influenza

United States
Sanofi Pasteur, a Sanofi Company

Completed

Trial to Describe the Safety and Immunogenicity of Fluzone®

Influenza

United States
MDVI, LLC
United States Department of Defense

Completed

T-705a Multicenter Study in Adults Subjects With Uncomplicated Influenza (FAVOR)

Influenza

United States
Columbia University

Completed

TextFluenza: Using Technology To Promote Flu Vaccination In Underserved Maternal And Child Populations

Influenza

United States
Columbia University

Completed

Vaccine Health Literacy Related Text Message Reminders to Increase Receipt of Second Dose of Influenza Vaccine for Young, Low Income, Urban Children

Influenza

United States
Columbia University

Completed

Adult Influenza Vaccination Text Message Reminders With Electronic Health Record Alerts

Influenza

United States
University of Pittsburgh

Completed

From Innovation to Solutions: Childhood Influenza Vaccination Planning

Influenza

United States
VaxInnate Corporation
University of Colorado, Denver

Completed

Study to Investigate the Immune Response to Two Doses of VAX102 Healthy Adults

Influenza

United States
National Institute of Allergy and Infectious Diseases...

Completed

Young Adult Influenza Vaccine Immunogenicity Substudy

Influenza

United States
National Institute of Allergy and Infectious Diseases...

Completed

Pilot Study of Genotypic Analysis

Influenza

United States
Akron Children's Hospital

Completed

Influenza Vaccination for Parents and Other Caregivers in the Pediatric Medical Home

Influenza

United States
AlphaVax, Inc.

Completed

A Safety and Immunogenicity Trial in Adults 65 Years of Age or Over to Prevent Influenza (AVX502-003)

Influenza

United States
National Institute of Allergy and Infectious Diseases...

Completed

Inactivated Influenza A/H9N2 Vaccine With and Without MF59 Adjuvant in Ambulatory Adults

Influenza

United States
National Institute of Allergy and Infectious Diseases...
Aviron LLC

Completed

Study of a Flu Vaccine in Children

Influenza

United States
National Institute of Allergy and Infectious Diseases...

Completed

St. Jude Open Label H5 Trial

Influenza

United States
Boston Children's Hospital
Centers for Disease Control and Prevention

Completed

Testing a Personally Controlled Health Record to Ameliorate Influenza at MIT (Indivo at MIT)

Influenza

United States
AlphaVax, Inc.

Completed

A Phase 1/2 Clinical Trial of an Alphavirus Replicon Vaccine for Influenza

Influenza

United States
The Cleveland Clinic

Completed

Influenza Vaccination in Bone Marrow Transplantation

Influenza

United States
The New York Academy of Medicine

Unknown

Rapid Vaccination of Hard-To-Reach Populations

Influenza

United States
Emory University
National Institute of Allergy and Infectious Diseases (NIAID)

Recruiting

Bone Marrow and Peripheral Blood Immune Responses Study

Influenza

United States
Weill Medical College of Cornell University
Genentech, Inc.

Recruiting

Baloxavir in Combination With Oseltamivir in Allogenic Bone Marrow Transplant Recipients With Influenza

Influenza

United States
Northwestern University

Completed

Influenza Vaccine Responses as a Means of Assessing Immune Competence in Chimeric Kidney/Stem Cell Transplant Recipients

Influenza

United States
University of Alabama at Birmingham

Active, not recruiting

Live Attenuated Influenza Vaccine as a Nasal Model for Influenza Infection

Influenza

United States
Emory University

Terminated

The Impact of Imprinting and Repeated Influenza Vaccination on Adaptive Immunity, Transcriptomics, and Metabolomics (FLU2)

Influenza

United States
Stanford University
National Institute of Allergy and Infectious Diseases (NIAID)

Terminated

Kinetics of B-Cell Responses to Live, Attenuated Influenza Vaccine (LAIV) in Young Children Two Years of Age (SLVP016)

Influenza

United States
MedImmune LLC
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Trial to Investigate Immune Responses Elicited by a Liquid Formulation of Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold Adapted (CAIV-T) in Healthy Adults

Influenza

United States
National Institute of Allergy and Infectious Diseases...

Completed

Influenza HA Ferritin Vaccine, Alone or in Prime-Boost Regimens With an Influenza DNA Vaccine in Healthy Adults

Influenza

United States
Insight Therapeutics, LLC
University Hospitals Cleveland Medical Center; Case Western Reserve University and other collaborators

Active, not recruiting

Immunogenicity of Influenza Vaccine in Long Term Care

Influenza

United States
michael macknin
Pharmacare Laboratories

Completed

Evaluating The Safety And Clinical Efficacy Of Elderberry Extract In Patients With Influenza

Influenza, Human

United States
University of Wisconsin, Madison

Completed

Influenza Vaccine in Lung Transplant Patients - Persistence of Antibodies

Influenza

United States
University of Wisconsin, Madison

Completed

Influenza Vaccine in Lung Transplant Patients - T Cells

Influenza

United States
University of Wisconsin, Madison

Completed

Influenza Vaccine in Lung Transplant Patients - Antibody

Influenza

United States
Stanford University
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Innate and Acquired Immunity to Influenza Infection and Immunization (SLVP029)

Influenza

United States
Emory University

Completed

Systems Biology of Flu Vaccine in Healthy Adults With and Without the Use of Antibiotics (VAX-002)

Influenza

United States
Kaiser Permanente
Centers for Disease Control and Prevention

Completed

A Comparison of One Versus Two Doses of Influenza Vaccine in Children 5-8 Years of Age

Influenza

United States
Stanford University
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Comparison of Immune Responses to Influenza Vaccine In Adults of Different Ages (SLVP015 2007-2017)

Influenza

United States
National Institute of Allergy and Infectious Diseases...

Completed

Safety and Dose Study of Peramivir for Influenza Treatment

Influenza

United States
University of Pittsburgh
Sanofi Pasteur, a Sanofi Company

Completed

Randomized Trial of High Dose Influenza Vaccine in Long Term Care Setting

Influenza

United States
Stanford University
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

T-cell And General Immune Response to Seasonal Influenza Vaccine (SLVP018) - Year 1, 2009

Influenza

United States
Sanofi Pasteur, a Sanofi Company

Completed

A Study to Evaluate the Safety and Immune Responses to Fluzone® Vaccination

Influenza

United States
National Institute of Allergy and Infectious Diseases...

Completed

Influenza A 2009 H1N1 Challenge Study in Healthy Adults

Influenza

United States
Sanofi Pasteur, a Sanofi Company

Completed

Phase IV Trial to Determine the Safety and Immunogenicity of the WHO Formulation of the 2006-2007 Fluzone® Vaccine

Influenza

United States
Sanofi Pasteur, a Sanofi Company

Completed

Trial to Collect Safety Data and Sera for Immunogenicity Testing

Influenza

United States
Sanofi Pasteur, a Sanofi Company

Completed

Safety and Immunogenicity of the World Health Organization (WHO) Formulation of the 2004-2005 Fluzone® Vaccine

Influenza

United States
Visterra, Inc.

Completed

A Study of VIS410 to Assess Safety and Pharmacokinetics

Influenza

United States
Columbia University
Agency for Healthcare Research and Quality (AHRQ)

Completed

FluAlert: Influenza Vaccine Alerts for Providers in the Electronic Health Record

Influenza

United States
The Cleveland Clinic

Completed

Impact of Influenza Vaccination in Pregnancy Video Education

Influenza

United States
National Institute of Allergy and Infectious Diseases...

Completed

Safety, Reactogenicity, and Immunogenicity of Inactivated Influenza A/H7/N7 Vaccine in Healthy Adults

Influenza

United States
Fred Hutchinson Cancer Center

Completed

TCAD vs. Monotherapy for Influenza A in Immunocompromised Patients

Influenza

United States
Sarepta Therapeutics, Inc.

Terminated

Safety Study of Single Administration Intravenous Treatment for Influenza

Influenza

United States

Clinical Trials on Influenza in Birds in United States

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Tanzania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations